Literature DB >> 26835558

Predominant role of spinal P2Y1 receptors in the development of neuropathic pain in rats.

Paulino Barragán-Iglesias1, Jorge Baruch Pineda-Farias2, Mariana Bravo-Hernández2, Claudia Cervantes-Durán2, Theodore J Price3, Janet Murbartián2, Vinicio Granados-Soto4.   

Abstract

The role of P2X2/3, P2X3, P2X4 or P2X7 and P2Y2, P2Y6, and P2Y12 receptors in neuropathic pain has been widely studied. In contrast, the role of P2Y1 receptors is scarcely studied. In this study we assessed the role of P2Y1 receptors in several neuropathic pain models in the rat. Furthermore, we analyzed the expression of P2Y1 receptors in the ipsilateral dorsal root ganglia (DRG) and dorsal part of the spinal cord during the development and maintenance of neuropathic pain. We also determined the effect of the P2Y1 receptor antagonist on the expression of P2Y1 receptors. Chronic constriction injury (CCI), spared nerve injury (SNI) or spinal nerve ligation (SNL) produced tactile allodynia from 1 to 14 days after nerve injury. CCI, SNI and SNL enhanced expression of P2Y1 receptors in DRG but not in the dorsal part of the spinal cord at 1-3 days after injury. Intrathecal injection of the selective P2Y1 receptor antagonist MRS2500, but not vehicle, reduced tactile allodynia in rats 1-3 days after CCI, SNI, or SNL. Moreover, intrathecal injection of MRS2500 (at day 1 or 3) reduced neuropathy-induced up-regulation of P2Y1 receptors expression. Intrathecal injection of MRS2500 lost most of the antiallodynic effect when injected 14 days after injury. At this time, MRS2500 did not modify nerve-injury-induced P2Y1 receptors up-regulation. Our results suggest that P2Y1 receptors are localized in DRG, are up-regulated by nerve injury and play a pronociceptive role in development and, to a lesser extent, maintenance of neuropathic pain.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Neuropathic pain; P2Y(1) receptors; Spinal cord; Tactile allodynia

Mesh:

Substances:

Year:  2016        PMID: 26835558      PMCID: PMC4919982          DOI: 10.1016/j.brainres.2016.01.042

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

Review 1.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Authors:  Eduardo R Lazarowski; Richard C Boucher; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

2.  Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury.

Authors:  Kimiko Kobayashi; Hiroki Yamanaka; Fujio Yanamoto; Masamichi Okubo; Koichi Noguchi
Journal:  Glia       Date:  2012-06-26       Impact factor: 7.452

3.  P2Y1 purinergic receptors in sensory neurons: contribution to touch-induced impulse generation.

Authors:  F Nakamura; S M Strittmatter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 4.  Purinergic signalling: from normal behaviour to pathological brain function.

Authors:  Geoffrey Burnstock; Ute Krügel; Maria P Abbracchio; Peter Illes
Journal:  Prog Neurobiol       Date:  2011-09-01       Impact factor: 11.685

5.  P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain.

Authors:  Jun Chen; Lina Wang; Yanbing Zhang; Jianping Yang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-02-19       Impact factor: 3.848

6.  Efficient analysis of experimental observations.

Authors:  W J Dixon
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

7.  Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats.

Authors:  Prisca Honore; Karen Kage; Joseph Mikusa; Andrew T Watt; Joseph F Johnston; Jacqueline R Wyatt; Connie R Faltynek; Michael F Jarvis; Kevin Lynch
Journal:  Pain       Date:  2002-09       Impact factor: 6.961

8.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

9.  Role of spinal P2Y6 and P2Y11 receptors in neuropathic pain in rats: possible involvement of glial cells.

Authors:  Paulino Barragán-Iglesias; Jorge Baruch Pineda-Farias; Claudia Cervantes-Durán; Mariana Bravo-Hernández; Héctor Isaac Rocha-González; Janet Murbartián; Vinicio Granados-Soto
Journal:  Mol Pain       Date:  2014-05-20       Impact factor: 3.395

10.  Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents.

Authors:  Gergely Horváth; Flóra Gölöncsér; Cecilia Csölle; Kornél Király; Rómeó D Andó; Mária Baranyi; Bence Koványi; Zoltán Máté; Kristina Hoffmann; Irina Algaier; Younis Baqi; Christa E Müller; Ivar Von Kügelgen; Beáta Sperlágh
Journal:  Neurobiol Dis       Date:  2014-06-25       Impact factor: 5.996

View more
  6 in total

1.  P2X7 receptor antagonist BBG inhibits endoplasmic reticulum stress and pyroptosis to alleviate postherpetic neuralgia.

Authors:  Yuyou Zhu; Siping Zhang; Yuanbo Wu; Juan Wang
Journal:  Mol Cell Biochem       Date:  2021-05-12       Impact factor: 3.396

2.  Microencapsulated Schwann cell transplantation inhibits P2X3 receptor expression in dorsal root ganglia and neuropathic pain.

Authors:  Ya-Ling Zhang; De-Jian Chen; Bao-Lin Yang; Tao-Tao Liu; Jia-Juan Li; Xiu-Qi Wang; Guo-Yong Xue; Zeng-Xu Liu
Journal:  Neural Regen Res       Date:  2018-11       Impact factor: 5.135

3.  P2Y6 Receptor-Mediated Spinal Microglial Activation in Neuropathic Pain.

Authors:  Jiang Bian; Ying Zhang; Yan Liu; Qun Li; Hai-Bin Tang; Qing Liu
Journal:  Pain Res Manag       Date:  2019-06-03       Impact factor: 3.037

4.  A Role for Global DNA Methylation Level and IL2 Expression in the Transition From Acute to Chronic Low Back Pain.

Authors:  Olivia C Eller; Nicole Glidden; Brittany Knight; Noelle McKearney; Mallory Perry; Katherine M Bernier Carney; Angela Starkweather; Erin E Young; Kyle M Baumbauer
Journal:  Front Pain Res (Lausanne)       Date:  2021-09-27

5.  A Targeted Mutation Disrupting Mitochondrial Complex IV Function in Primary Afferent Neurons Leads to Pain Hypersensitivity Through P2Y1 Receptor Activation.

Authors:  Rory Mitchell; Graham Campbell; Marta Mikolajczak; Katie McGill; Don Mahad; Sue M Fleetwood-Walker
Journal:  Mol Neurobiol       Date:  2019-01-28       Impact factor: 5.590

6.  Treatment of chronic neuropathic pain: purine receptor modulation.

Authors:  Kenneth A Jacobson; Luigino Antonio Giancotti; Filomena Lauro; Fatma Mufti; Daniela Salvemini
Journal:  Pain       Date:  2020-07       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.